1-METHYL-1H-INDAZOLE-7-CARBOXYLIC ACID, 95%, 100mg

2,4-Bis(trifluoromethyl)benzylamine, 1g

1,3-Thiazol-2-ylmethanol, 96.0%, 10g

(S)-2-(2-(Diphenylphosphanyl)phenyl)-4-isopropyl-5,5-diphenyl-4,5-dihydrooxazole, 98%, 1g

Test tubes, 25 ml, Height, 53 mm, 50 Piece(s)

2-chloro-6-methoxy-3,4-dihydroquinazolin-4-one, 96.16%, 1g

Cyclobutanecarbohydrazide, 95.0%, 5g

6-BROMO-3,3-DIMETHYLINDOLIN-2-ONE, 95.0%, 5g

1-((Benzyloxy)carbonyl)-5-oxopiperidine-2-carboxylic acid, 98%, 10mg

2-Methyl-5-(1-methyl-1H-pyrazol-5-yl)benzoic acid, 97%, 250mg

(S)-BHPphos, 98.30%, 250mg

12,13-Dihydro-12,13-bis(2-octyldodecyl)-3,9-diundecyldithieno[2′′,3′′:4′,5′]thieno[2′,3′:4,5]pyrrolo[3,2-e:2′,3′-g][2,1,3]benzothiadiazole-2,10-dicarboxaldehyde, 98%, 100mg

Long working distance plan Fluarex 4x/0.13 infinity corrected IOS objective, corrected for 1 mm petri dish thickness